{{위키데이터 속성 추적}}
'''아자피론'''(Azapirone)은 불안 완화제, 항우울제 및 항정신병 약으로 사용되는 약물의 일종이다.<ref name="pmid1973936">{{저널 인용| author = Eison AS | title = Azapirones: history of development | journal = Journal of Clinical Psychopharmacology | volume = 10 | issue = 3 Suppl | pages = 2S–5S |date=June 1990 | pmid = 1973936 | doi = 10.1097/00004714-199006001-00002| url = }}</ref><ref name="pmid8638511">{{저널 인용| author = Cadieux RJ | title = Azapirones: an alternative to benzodiazepines for anxiety | journal = American Family Physician | volume = 53 | issue = 7 | pages = 2349–53 |date=May 1996 | pmid = 8638511 | doi = | url = }}</ref><ref name="pmid16856115">{{저널 인용| vauthors=Chessick CA, Allen MH, Thase M, Batista Miralha da Cunha AB, Kapczinski FF, de Lima MS, dos Santos Souza JJ | title = Azapirones for generalized anxiety disorder | journal = Cochrane Database of Systematic Reviews | volume = 3 | issue = 3| pages = CD006115 | year = 2006 | pmid = 16856115 | editor1-last = Chessick | editor1-first = Cheryl A |  doi = 10.1002/14651858.CD006115|display-authors=etal}}</ref><ref name="pmid2567039">{{저널 인용|vauthors=Feighner JP, Boyer WF | title = Serotonin-1A anxiolytics: an overview | journal = Psychopathology | volume = 22 Suppl 1 | issue = 1| pages = 21–6 | year = 1989 | pmid = 2567039 | doi = 10.1159/000284623| url = }}</ref> 이들은 일반적으로 [[선택적 세로토닌 재흡수 억제제]](SSRI)와 같은 다른 항우울제에 대한 추가 물질(Addon)로 사용될 수 있다.<ref>{{서적 인용|chapter-url = |chapter = Pharmacological treatment of social anxiety disorder|accessdate = |doi = 10.1159/000351960|pmid = 25225024 |volume=29 |year=2013 |pages=144–53 |vauthors=Masdrakis VG, Turic D, Baldwin DS|isbn = 978-3-318-02463-0|title = Anxiety Disorders|series = Modern Trends in Pharmacopsychiatry}}</ref><ref name="pmid8827420">{{저널 인용|vauthors=Van Ameringen M, Mancini C, Wilson C | title = Buspirone augmentation of selective serotonin reuptake inhibitors (SSRIs) in social phobia | journal = Journal of Affective Disorders | volume = 39 | issue = 2 | pages = 115–21 |date=July 1996 | pmid = 8827420 | doi = 10.1016/0165-0327(96)00030-4}}</ref><ref name="pmid9180827">{{저널 인용|vauthors=Bouwer C, Stein DJ | title = Buspirone is an effective augmenting agent of serotonin selective re-uptake inhibitors in severe treatment-refractory depression | journal = South African Medical Journal | volume = 87 | issue = 4 Suppl | pages = 534–7, 540 |date=April 1997 | pmid = 9180827 | doi = | url = }}</ref><ref name="pmid9864079">{{저널 인용|vauthors=Dimitriou EC, Dimitriou CE | title = Buspirone augmentation of antidepressant therapy | journal = Journal of Clinical Psychopharmacology | volume = 18 | issue = 6 | pages = 465–9 |date=December 1998 | pmid = 9864079 | doi = 10.1097/00004714-199812000-00009}}</ref><ref name="pmid11465522">{{저널 인용|vauthors=Appelberg BG, Syvälahti EK, Koskinen TE, Mehtonen OP, Muhonen TT, Naukkarinen HH | title = Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study | journal = The Journal of Clinical Psychiatry | volume = 62 | issue = 6 | pages = 448–52 |date=June 2001 | pmid = 11465522 | doi = 10.4088/JCP.v62n0608| url = }}</ref><ref name="pmid12667165">{{저널 인용|vauthors=Yamada K, Yagi G, Kanba S | title = Clinical efficacy of tandospirone augmentation in patients with major depressive disorder: a randomized controlled trial | journal = Psychiatry and Clinical Neurosciences | volume = 57 | issue = 2 | pages = 183–7 |date=April 2003 | pmid = 12667165 | doi = 10.1046/j.1440-1819.2003.01099.x}}</ref>

[[부스피론]]이 있다.

== 같이 보기 ==
* [[감마 아미노부티르산|GABA]]
* [[벤조디아제핀]]

== 각주 ==
{{각주}}

[[분류:아자피론| ]]